Celgene to stop blood cancer trial due to higher death rates

(Reuters) - Celgene Corp said it will stop a late-stage trial of its blood cancer drug Revlimid after it observed a higher number of deaths in patients taking the drug compared to those on a placebo. The trial was placed on a clinical hold by the ...

Source: http://health.yahoo.net/news/s/nm/celgene-to-stop-blood-cancer-trial-due-to-higher-death-rates

click here click here found here